切换至 "中华医学电子期刊资源库"

中华介入放射学电子杂志 ›› 2015, Vol. 03 ›› Issue (04) : 186 -190. doi: 10.3877/cma.j.issn.2095-5782.2015.04.003

所属专题: 专题评论 文献

血管介入

髋关节区动脉支架植入治疗下肢动脉重症缺血的临床效果评价
张曦彤1,(), 韩向军1, 张伟1, 刘大伟1, 梁松年1, 夏永辉1, 牛猛1   
  1. 1. 110001 沈阳,中国医科大学附属第一医院介入放射科
  • 收稿日期:2015-08-15 出版日期:2015-11-01
  • 通信作者: 张曦彤

Evaluation of the clinical effects on the treatment of arterial stent placement across hip joint for critical lower extremity ischemia

Xitong Zhang1,(), Xiangjun Han1, Wei Zhang1, Dawei Liu1, Songnian Liang1, Yonghui Xia1, Meng Niu1   

  1. 1. Department of Radiology, the First Hospital of China Medical University, Shenyang 110001, China
  • Received:2015-08-15 Published:2015-11-01
  • Corresponding author: Xitong Zhang
  • About author:
    Corresponding author: Zhang Xitong, Email:
引用本文:

张曦彤, 韩向军, 张伟, 刘大伟, 梁松年, 夏永辉, 牛猛. 髋关节区动脉支架植入治疗下肢动脉重症缺血的临床效果评价[J]. 中华介入放射学电子杂志, 2015, 03(04): 186-190.

Xitong Zhang, Xiangjun Han, Wei Zhang, Dawei Liu, Songnian Liang, Yonghui Xia, Meng Niu. Evaluation of the clinical effects on the treatment of arterial stent placement across hip joint for critical lower extremity ischemia[J]. Chinese Journal of Interventional Radiology(Electronic Edition), 2015, 03(04): 186-190.

目的

观察与评价髋关节区支架植入治疗下肢动脉重症缺血的安全性、有效性及对股深动脉血流的影响。

方法

66例动脉硬化闭塞所致下肢重症缺血患者(共70条动脉,均累及股总动脉和/或股动脉近心段)。平均年龄74.6岁。男46例,女20例。左下肢动脉40条,右下肢动脉30条。开通闭塞动脉后,行球囊扩张及支架植入。

结果

术中股动脉急性闭塞3例(局部溶栓后获得通畅),余下肢动脉即刻血流均获得通畅,下肢缺血症状均明显改善。术后15例患肢出现血流过度灌注,无严重并发症发生。随访54例(失访12例),随访时间2~30个月,平均(16.2±2.6)个月。25例因再狭窄或闭塞发生患肢缺血,其中16例接受再次介入治疗(PTA及导管溶栓后获二次通畅)。跨髋关节支架均无断裂,股深动脉均仍保持通畅。6例发生心、脑血管意外,其中2例死亡。

结论

跨髋关节动脉支架植入可安全、有效地改善下肢动脉重症缺血,且不影响股深动脉血流。

Objective

To evaluate the clinical safety and effect of arterial stent placement across hip joint for critical lower extremity ischemia and observe the influence of the stent on femoral profound artery patency.

Methods

Sixty-six patients (male 46, female 20) who aged 50-88 years (mean 74.6 years) with critical lower extremity ischemia caused by arteriosclerosis occlusion were reviewed in our study. The total 70 arterial lesions involved the common femoral arteries and/or proximal SFAs. The angioplasty and stents placement after successful canalization was performed in left (40 limbs) and right lower extremity arteries (30 limbs).

Results

The acute thrombosis occurred in three SFAs during the operation, but was dissolved by catheter directed thrombolysis. The other arteries got patency immediately. All ischemia were improved obviously. Fiveteen patients had blood hyper-perfusion in implicated limbs but no severe complication occurred. The follow-up time were (16.2±2.6) months (2-30 months) among 54 cases, the other 12 cases were lost to follow-up. The ischemia due to stenosis or occlusion recurred in 25 cases. Among them, 16 patients received the re-interventional therapy (PTA or catheter directed thrombolysis) and got satisfactory results. In all stents across the hip joint, no fracture occurred and the femoral profound arteries were still patency proved by CTA and DSA examination. Two of six patients with cardiac arrest or stoke died during the follow-up.

Conclusions

Arterial stents placement across hip joint is a safe and effective therapy for critical lower extremity ischemia, and the fluency of femoral profound artery is not affected.

图1 患者 男,71岁,右下肢跛行伴静息痛Rutherford-BeckerⅡ级。A:右SFA长段闭塞;B:SFA近心端(髋关节区)植入支架前造影,判断待植入支架长度;C:支架植入后,近心端位于股深动脉开口上方约6 mm;D:术后9个月患者无下肢缺血症状,复查CTA显示支架无变形、断裂,股深动脉通畅。
图2 患者 女,79岁,左下肢静息痛伴足趾部皮肤破损,Rutherford-Becker Ⅲ级。A、B:CTA及DSA显示左SFA长段闭塞;C:植入3枚支架后,股动脉血流通畅,支架近心端位于股深动脉开口上方约1 cm;D:术后14个月动脉再闭塞(支架仍完整、无断裂),股深动脉仍通畅;E:经球囊扩张后;F:左SFA再次获得通畅。
1
Schillinger M, Sabeti S, Loewe C, et al. Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery. N Engl J Med, 2006,354(18):1879-1888.
2
Vogel TR, Shindelman LE, Nackman GB, et al. Efficacious use of nitinol stents in the femoral and popliteal arteries[J]. J Vasc Surg,2003, 38(6):1178-1184.
3
Mewissen MW. Self-expanding nitinol stents in the femoropopliteal segment: technique and mid-term results[J]. Tech Vasc Interv Radiol,2004, 7(1):2-5.
4
Sabeti S, Schillinger M, Amighi J, et al. Primary patency of femoropopliteal arteries treated with nitinol versus stainless steel self-expanding stents: propensity score- adjusted analysis[J]. Radiology, 2004, 232(2):516-521.
5
Bray PJ, Robson WJ, Bray AE. Percutaneous treatment of long superficial femoral artery occlusive disease: efficacy of the Hemobahn stent-graft[J]. J Endovasc Ther, 2003,10(3):619-628.
6
Wiesinger B, Beregi JP, Oliva VL, et al. PTFE-covered self-expanding nitinol stents for the treatment of severe iliac and femoral artery stenoses and occlusions: final results from a prospective study[J]. J Endovasc Ther,2005,12(2):240-246.
7
Fischer M, Schwabe C, Schulte KL. Value of the hemobahn/viabahn endoprosthesis in the treatment of long chronic lesions of the superficial femoral artery: 6 years of experience[J]. J Endovasc Ther,2006,13(3):281-290.
8
Lenti M, Cieri E, De Rango P, et al. Endovascular treatment of long lesions of the superficial femoral artery: results from a multicenter registry of a spiral, covered polytetrafluoroethylene stent[J]. J Vasc Surg, 2007,45(1):32-39.
9
Krankenberg H, Schlüter M, Steinkamp HJ, et al. Nitinol stent implantation versus percutaneous transluminal angioplasty in superficial femoral artery lesions up to 10 cm in length: the femoral artery stenting trial (FAST) [J]. Circulation, 2007, 116(3):285-292.
10
Rutherford RB,Backer DJ, Ernst C, et al. Recommended standards for reports dealing with lower extremity ischemia: Revised vision. J Vasc Surg,1997,26(3):517-538.
11
Klein WM, van der Graaf Y, Seegers J, et al. Dutch iliac stent trial: long-term results in patients randomized for primary or selective stent placement[J].Radiology, 2006,238(2):734-744.
12
Klein WM, van der Graaf Y, Seegers J, et al. Dutch iliac stent trial: long-term results in patients randomized for primary or selective stent placement[J].Radiology, 2006,238(2):734-744.
13
Daenens K, Maleux G, Fourneau I, et al. Hemobahn stent-grafts in the treatment of femoropopliteal occlusive disease[J]. J Cardiovasc Surg (Torino), 2005,46(1):25-29.
14
Cheng SW, Ting AC, Wong J. Endovascular stenting of superficial femoral artery stenosis and occlusions: results and risk factor analysis[J]. Cardiovasc Surg,2001, 9(2):133-140.
15
Jahnke T, Andresen R, Müller-Hülsbeck S, et al. Hemobahn stent-grafts for treatment of femoropopliteal arterial obstructions: midterm results of a prospective trial[J]. J Vasc Interv Radiol, 2003,14(1):41-51.
16
张曦彤,徐克,杨东炜,等.镍钛合金支架治疗长段股动脉完全闭塞的技术与结果[J].中国医学影像技术,2008,24(3):424-426.
[1] 戴云, 徐超丽, 林秀玉, 孙晖, 李娟, 宋秋怡, 王晓春, 杨斌. 超声造影评价移植肾动脉狭窄支架治疗短期疗效的临床价值[J]. 中华医学超声杂志(电子版), 2023, 20(03): 301-306.
[2] 郭璐琦, 赵雅琦, 李霁欣, 周兰, 林金鹏, 张子砚, 李俊杰, 王少白. 免荷矫形器对膝骨关节炎的生物力学影响的研究进展[J]. 中华关节外科杂志(电子版), 2023, 17(04): 560-565.
[3] 刘虹宏, 杨永红, 张冬花, 林运. 老年冠脉分叉病变主支支架植入后在损伤边支使用药物涂层球囊进行修复的临床研究[J]. 中华损伤与修复杂志(电子版), 2023, 18(05): 387-393.
[4] 张海涛, 康婵娟, 翟静洁. 胰管支架置入治疗急性胆源性胰腺炎效果观察[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 654-657.
[5] 钟文文, 李科, 刘碧好, 蔡炳, 脱颖, 叶雷, 马波, 瞿虎, 汪中扬, 王德娟, 邱剑光. 不同比例聚乳酸/丝素蛋白复合支架在兔尿道缺损修复中的疗效[J]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(05): 516-522.
[6] 张翼飞, 郭强, 赖华健, 钟文文, 叶雷, 马波, 瞿虎, 尧冰, 邱剑光, 王德娟. 加速康复外科在儿童尿道下裂围术期的应用效果分析[J]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(04): 367-371.
[7] 范小彧, 孙司正, 鄂一民, 喻春钊. 梗阻性左半结肠癌不同手术治疗方案的选择应用[J]. 中华结直肠疾病电子杂志, 2023, 12(06): 500-504.
[8] 文华伟, 汤明, 方禹舜, 李亚楠, 张绍华, 张青松. 生物材料增强肩袖腱骨愈合的研究进展[J]. 中华肩肘外科电子杂志, 2023, 11(03): 273-278.
[9] 曹玲, 张业坡, 袁珊珊, 胡红杰, 余日胜. 恶性胆道梗阻行胆道支架置入术后危重并发症及其危险因素研究[J]. 中华消化病与影像杂志(电子版), 2023, 13(04): 203-210.
[10] 许少睿, 孔杰, 马骏, 尚金林, 苏浩波. 西门子Artis Zee系列神经介入术专属透视策略的创建与应用[J]. 中华介入放射学电子杂志, 2023, 11(04): 318-323.
[11] 吴佳霖, 罗骏阳, 钟胜, 王有枝, 姜在波. 肝内小直径覆膜支架联合抽栓、溶栓治疗门静脉血栓二例[J]. 中华介入放射学电子杂志, 2023, 11(04): 377-379.
[12] 杨伟洪, 向先俊, 郭宗锦, 王亮, 周汝明, 魏民新, 王赞鑫. 主动脉夹层累及腹腔分支二期腔内治疗的中期研究[J]. 中华介入放射学电子杂志, 2023, 11(03): 236-240.
[13] 霍小森, 刘言, 董延妍, 边灵杰, 李媛, 李磊, 安鹏, 王洪武. 双支架联合治疗晚期肺癌致中心气道狭窄及上腔静脉综合征一例[J]. 中华介入放射学电子杂志, 2023, 11(03): 292-294.
[14] 袁畅, 李志刚. 胸部恶性肿瘤相关气管食管瘘的诊治进展[J]. 中华胸部外科电子杂志, 2023, 10(04): 241-246.
[15] 陆东生, 桂建康, 范衍, 刘春林, 李祉岑, 宫崧峰. 复合手术治疗椎动脉慢性闭塞一例[J]. 中华脑血管病杂志(电子版), 2023, 17(04): 386-393.
阅读次数
全文


摘要